Literature DB >> 21353473

Echocardiographic determination of the prevalence of primary myxomatous degeneration of the cardiac valves.

Yihua He1, Youmin Guo, Zhian Li, Jian Chen, Michael C Kontos, Walter H J Paulsen, Jiancheng Han, Linlin Wang, Xiaoyan Gu, J V Ian Nixon.   

Abstract

BACKGROUND: There is a paucity of data on the prevalence of primary myxomatous degeneration (PMD) of the cardiac valves. Because the gold standard for the diagnosis is pathology, its preoperative detection rate is relatively low. The purposes of this study were to determine the capability of echocardiography to identify PMD compared with surgical pathological findings and to determine the echocardiographic features of PMD.
METHODS: Echocardiograms were retrospectively compared with pathologic findings in 1,080 patients undergoing surgery for moderate or severe cardiac valve regurgitation. PMD of the mitral, aortic, and tricuspid valves was retrospectively identified, with a comparison of the echocardiographic and pathologic findings, to estimate the prevalence of PMD and to summarize its echocardiographic features.
RESULTS: Of 1,080 patients, 104 were diagnosed with PMD (prevalence, 9.62%). Echocardiography identified valvular prolapse and thickening in 85% of patients. The echocardiographic characteristics of PMD included valvular regurgitation, valvular thickening, valvular prolapse, and rupture of chordae tendineae. Combinations of these characteristics were seen on multiple valves. Among patients with PMD, 59 had only mitral valve involvement, 25 had only aortic valve involvement, two had only tricuspid valve involvement, 10 had both mitral and aortic valve involvement, and three had both mitral and tricuspid valve involvement.
CONCLUSIONS: In patients undergoing surgery for valvular regurgitation, a high prevalence of PMD was found. PMD has distinctive echocardiographic features, suggesting its preoperative diagnosis.
Copyright © 2011 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21353473     DOI: 10.1016/j.echo.2011.01.001

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  5 in total

1.  Echocardiographic versus histologic findings in Marfan syndrome.

Authors:  Xiaoyan Gu; Yihua He; Zhian Li; Jiancheng Han; Jian Chen; J V Ian Nixon
Journal:  Tex Heart Inst J       Date:  2015-02-01

2.  Cardiac masses : Experience from a Turkish tertiary center of cardiology.

Authors:  C Gecmen; G G Gecmen; M Kahyaoglu; B Omar; S Izci; A Kalayci; C Y Karabay; S Coban; O Candan; E Yanik; I A Izgi; N O Barisik
Journal:  Herz       Date:  2016-12-01       Impact factor: 1.443

3.  Aortic valve insufficiency due to myxomatous degeneration: a case report and literature review.

Authors:  Basel Abdelazeem; Rachel M Hollander; Tyler M Gresham; Rudin Gjeka; Arvind Kunadi
Journal:  AME Case Rep       Date:  2022-01-25

4.  Distinct mitral valve proteomic profiles in rheumatic heart disease and myxomatous degeneration.

Authors:  Carlo de Oliveira Martins; Keity Souza Santos; Frederico Moraes Ferreira; Priscila Camillo Teixeira; Pablo Maria Alberto Pomerantzeff; Carlos Ma Brandão; Roney Orismar Sampaio; Guilherme S Spina; Jorge Kalil; Luiza Guilherme; Edecio Cunha-Neto
Journal:  Clin Med Insights Cardiol       Date:  2014-08-27

5.  Rheumatic Heart Disease and Myxomatous Degeneration: Differences and Similarities of Valve Damage Resulting from Autoimmune Reactions and Matrix Disorganization.

Authors:  Carlo de Oliveira Martins; Lea Demarchi; Frederico Moraes Ferreira; Pablo Maria Alberto Pomerantzeff; Carlos Brandao; Roney Orismar Sampaio; Guilherme Sobreira Spina; Jorge Kalil; Edecio Cunha-Neto; Luiza Guilherme
Journal:  PLoS One       Date:  2017-01-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.